In a research report issued today, Oppenheimer analyst Rohit Vanjani maintained an Outperform rating on OvaScience Inc (NASDAQ:OVAS) with a $60 price target, after hosting investor …
In a research note published today, H.C.
In a research report issued today, Oppenheimer analyst Rohit Vanjani downgraded shares of OvaScience Inc (NASDAQ:OVAS) to Perform from an Outperform rating, as shares of OvaScience …